In every issue, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.
Also Available On:
Though it turned 20 this year, HIV barely even took a cake break from punching our digits like a bullying bill collector.
Out of the ashes of HIV eradication, the phoenix of immune reconstitution is rising.
China finally breaks its infamous silence about AIDS. But will the regime loosen its iron fist enough to save millions of lives?
David Welch, 42, has the heart of a girl -- a 14-year-old one, to be exact.
Two years after washington state started tracking HIV cases by name, experts remain split on whether public health or politics is best...
Did polio-vax monkey business start AIDS?
If San Fran’s Board of Supervisors gets its way, ’80s-era warnings about the dangers of amyl nitrate -- a.k.a. poppers -- will be back.
POZ columnist Emily Carter won a Whiting award for her stories, Glory Goes and Gets Some.
On October 14, Colombia’s most respected newspaper, El Tiempo, reported that Marxist rebels had forced over 20,000 people to undergo HIV...
California’s AIDS Ride hits a wall
Dark and strong at the Poets’ Café
Add some color to your under-the-mistletoe smooches, with MAC Cosmetics’ Viva Glam lipstick.
Two of the epidemic’s best poets offer new collections this month.
Gary Norton, 53, lost a 12-year battle with AIDS on October 9.
After years in the scientific wilderness, HIV vaccine research is finding its way.
The good news about this vaccine-research sea change for people already infected is that many new candidates show promise as treatments, too
The anthrax anxiety has literally brought home pharma economics in a way AIDS never did.
Schering-plough has long taken heat for packaging, or “bundling,” its hepatitis C treatment, interferon and ribavirin.
Lush life and lipo? A Mass General study found that spirits can raise cholesterol levels that promote lipo.
A German study found that treating hep C with interferon alpha-2b soon after infection can prevent chronic liver disease.
On October 26, Gilead’s tenofovir (Viread) became the only new anti-HIV drug to win FDA OK this year.
An HIV diagnosis no longer automatically excludes you from a lifesaving organ transplant.
Have you ever wanted something specific to eat, but you didn’t know what?
Vagina DialoguesI am going to fight your magazine till death now! How dare you say that I, for examp
The Bish is back with succor for the holiday soul